Medozil (Donepezil Hydrochloride)

Donepezil Hydrochloride works by reversibly inhibiting the enzyme acetylcholinesterase. This inhibition prevents the breakdown of acetylcholine, leading to higher levels of this neurotransmitter in the central nervous system, which supports cognitive processes that are typically reduced in Alzheimer’s disease.

The specific dose of Medozil is determined by the prescribing physician based on the patient’s clinical condition, age, and response to therapy. Dosage adjustments are made according to individual therapeutic needs and tolerability.

The safety of Donepezil Hydrochloride in pregnancy or while breastfeeding has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Medozil product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Medozil (Donepezil) is a reversible acetylcholinesterase inhibitor, similar to rivastigmine and galantamine. Compared with these agents, Donepezil generally requires once‑daily dosing and has a well‑characterized safety profile, though individual response and tolerability can vary among patients.

Medozil should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and ensure they are out of reach of children.

Medozil is taken orally, usually with a glass of water. The tablet should be swallowed whole and not chewed or crushed. It can be taken with or without food, according to the prescribing physician’s instructions.

Serious risks include bradycardia, cardiac conduction abnormalities, severe hepatic injury, and rare cases of seizures or allergic reactions such as rash or angioedema. Patients should be monitored regularly for any signs of these adverse events.

Medozil is contraindicated in patients with known hypersensitivity to Donepezil or any of its excipients, and it should be used with caution in individuals with severe cardiac conduction disorders, uncontrolled asthma, or a history of seizures. A healthcare professional should evaluate suitability before prescribing.